SEINE BIO · Research, evidence & your next steps
The science behind pigment signaling.
Explore how melanocortin biology connects to a specialist medical application. Afamelanotide has a defined role in an approved implant; the exact formulation and intended use make the difference.
Evidence for an approved medicine does not establish approval or equivalence of this catalog formulation.
How Melanotan 1 works
Afamelanotide is a melanocortin analogue that influences melanin production. The approved medicine Scenesse is a subcutaneous implant used to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP).
Why it’s getting attention
Scenesse’s approval is for a specialist implant and a specific disease—not a cosmetic tanning vial, cartridge or pen. The catalog name alone does not establish identical identity, formulation, delivery or regulatory approval.
Protocol reference at a glance
Reference context, not your prescription. Reference example only: Scenesse for adult EPP. This is not a Melanotan I vial or pen protocol.
| Stage | What to expect from the evidence |
|---|---|
| Approved-reference schedule | One 16 mg implant every two months Administered by a trained healthcare professional for the labeled EPP indication. |
| Loading / starting injection | No validated tanning-vial loading schedule established here The implant must not be converted into daily injections. |
| Maintenance / maximum | The implant label governs specialist treatment No established safe cosmetic injection maximum or maintenance cycle. |
| Monitoring | Skin and mole assessment as directed by the reference label Continued sun-protection measures remain important. |
Presentation & administration
The approved reference uses a professionally administered subcutaneous implant. A ready-to-use vial, cartridge, disposable pen or nasal spray is not an equivalent implant.
Catalog presentation: Vial / Cartridge / Disposable Injection Pen. Listed strength options: 10 mg. One catalog unit is one selected presentation—not a box containing every pictured format. Total container content is not a personal dose, and an illustration does not verify an approved route or device.
Risks & common side effects
- Reference-label risks include pigment changes, darkening of existing moles, implant-site reactions and hypersensitivity. New or changing lesions need assessment.
- A tan does not establish UV protection. Do not use tanning beds or deliberate UV exposure as a dosing aid.
Tell your clinician about new or persistent symptoms and other medicines. Changes to treatment should be clinician-directed.
Other options worth discussing
For cosmetic color, consider externally applied sunless tanners or bronzers with ongoing sun protection. For EPP, seek a specialist rather than substituting a catalog product for the approved implant. “More established” does not mean risk-free or suitable for everyone; a clinician should compare benefits, contraindications and your preferences.
When to seek help
Breathing difficulty or facial swelling needs emergency care; unexpected skin changes or persistent symptoms require clinical review.
Finished-product quality, concentration and route require verification. Review allergies, pregnancy, health conditions and other medicines with your clinician.
Do not wait for a portal reply in an emergency. Call 911 or seek emergency care for severe or rapidly worsening symptoms.
A few useful answers
Is this listing the same as Scenesse?
Not established. The approved implant, exact formulation and clinical indication are different from this catalog presentation.
Can the implant dose be divided into injections?
No. Implant release and injection dosing are not interchangeable.
Does clinician authorization guarantee access?
No. Clinical appropriateness, lawful availability and a verified finished formulation must each be established. An Rx setting, luxury image or research-series label does not create regulatory approval.
Research & references
General information, not a prescription or a guarantee of results. Research and reference-label schedules do not replace instructions for your exact prescribed product. Clinical suitability and lawful availability require separate confirmation.
Make your next step an informed one.
Share what you want to improve, what you have already tried, and the questions you have about Melanotan 1. Your care team can help put the evidence and alternatives in context.
Sign-in may be required. This is not an emergency service or a guarantee that this product is available.